Paper

Loss-of-function mutation in human Oxidation Resistance gene 1 disrupts the spatial-temporal regulation of histone arginine methylation in early brain development

Wang, Wei, Kuśnierczyk, Anna, Yang, Mingyi, Ming, Guo-li, Elpeleg, Orly, Kissova, Miroslava, Almaas, Runar, Abu-Libdeh, Bassam, Kristiansen, Elise, Shahrour, Maher, Tang, Wannan, Lång, Anna, Siller, Richard, van Loon, Barbara, Pannone, Marco, Edvardson, Simon, de Sousa, Mirta Mittelstedt Leal, Ye, Jing, Slupphaug, Geir, Bøe, Stig Ove, Rinholm, Johanne Egge, Bjørås, Magnar, Damseh, Nadirah, Eide, Lars, Al-Ashhab, Motee, Lin, Xiaolin, Jacob, Fadi, Sullivan, Gareth J, Song, Hongjun

2022

Overview

We report a loss-of-function mutation in the TLDc domain of human Oxidation Resistance 1 (OXR1) gene, resulting in early-onset epilepsy, developmental delay, cognitive disabilities, and cerebellar atrophy. Patient lymphoblasts show impaired cell survival, proliferation, and hypersensitivity to oxidative stress. These phenotypes are rescued by TLDc domain replacement. We generated patient derived induced pluripotent stem cells (iPSCs) revealing impaired neural differentiation along with dysregulation of genes essential for neurodevelopment. We identified that OXR1 influences histone arginine methylation by activating protein arginine methyltransferases (PRMTs), suggesting OXR1 dependent mechanisms regulating gene expression during neurodevelopment. We modeled the function of OXR1 in early human brain development using patient derived brain organoids revealing that OXR1 contributes to the spatial-temporal regulation of histone arginine methylation in specific brain regions. Our work provides new insights into pathological features and molecular underpinnings associated with OXR1 deficiency, highlighting the therapeutic potential of OXR1 in numerous neurodegenerative and neurodevelopmental disorders.

• Publisher: Cold Spring Harbor Laboratory
• Subject: Pathology